IRADIMED CORP Operating Income Loss

Quick Answer

IRADIMED CORP reported Operating Income Loss of $26.15 million for the year ending 2025.

  • IRADIMED CORP showed an increase of +19.0% in Operating Income Loss from 2024 to 2025.
  • This data is from IRADIMED CORP's annual report (Form 10-K), filed with the SEC on March 6, 2026.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2013 to 2025), IRADIMED CORP's Operating Income Loss has grown by 838.1%.
  • Historical annual values: Fiscal year 2025: $26.15 million | Fiscal year 2024: $21.97 million | Fiscal year 2023: $20.04 million | Fiscal year 2022: $15.63 million | Fiscal year 2021: $9.82 million | Fiscal year 2020: -$756.1 thousand | Fiscal year 2019: $8.65 million | Fiscal year 2018: $6.00 million | Fiscal year 2017: $1.29 million | Fiscal year 2016: $10.92 million | Fiscal year 2015: $11.51 million | Fiscal year 2014: $3.07 million | Fiscal year 2013: $2.79 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: